Avandia & Strokes

Avandia has been shown in studies to increase the risk of stroke. About 700,000 Americans each year suffer a stroke, and there are different types. The ischemic type is caused by a blocked blood vessel and the intracerebral hemorrhagic (ICH) type is caused by a ruptured blood vessel. More than 65% of people with diabetes die from heart disease or stroke.

In April of 2007 the US Food and Drug Administration (FDA) approved safety labeling revisions to advise of the increased risk for cardiovascular events associated with use of rosiglitazone male ate tablets in patients with New York Heart Association class 1 and 2 cardiac status; the risks for stroke, and deep vein thrombosis.

Diabetic patients with a family history of heart disease, cardiovascular disease, stroke, or congestive heart failure have a higher risk of these conditions when taking Avandia than no diabetic patients.

What is an Avandia Stroke?

A stroke is a type of cardiovascular disease. It affects the arteries leading to and within the brain. A stroke occurs when a blood vessel that carries oxygen and nutrients to the brain is either blocked by a clot or bursts. When that happens, part of the brain cannot get the blood (and oxygen) it needs, so it starts to die.